Showing results (1-10 of 481) with videos related to
Sort By:
Pageof 49
Biologicals : Journal of the International Association of Biological Standardization|February 25, 2000
Safety issues for plasma derivatives and benefit from NAT testingH Willkommen, I Schmidt, J LöwerVox Sanguinis|March 21, 2002
Parvovirus B19 DNA in plasma pools and plasma derivativesI Schmidt, J Blümel, H Seitz, et al.Clinical Therapeutics|January 1, 1996
Prevalence of hepatitis C virus in plasma pools and the effectiveness of cold ethanol fractionationH Scheiblauer, M Nübling, H Willkommen, et al.Klinische Wochenschrift|April 15, 1986
Detection of antibodies to HTLV-III in commercially available immunoglobulin preparationsR Kurth, I Schmidt, A Werner, et al.Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 17, 2010
[Pandemic influenza vaccines. How should they be designed?]J LöwerJournal of Medical Virology|May 1, 1990
Risk of tumor induction in vivo by residual cellular DNA: quantitative considerationsJ LöwerArzneimittel-Forschung|March 1, 1988
[Gene technology in the diagnosis of viruses and vaccine development]J LöwerActa Virologica|September 1, 1983
The influence of pH and ionic strength on the single radial immunodiffusion test in qualitative assay of influenza virus haemagglutininH Willkommen, S Platen, H StäberVox Sanguinis|December 16, 1998
GB virus C/hepatitis G virus and intravenous immunoglobulinsC Nübling, A Gröner, J LöwerVaccine|December 12, 2001
Cold-attenuated live influenza vaccines, a risk-benefit assessmentM Pfleiderer, J Löwer, R KurthPageof 49